Skip to main content
OpenTrials

Clinical trial condition

Soft Tissue Sarcoma

Explore clinical trials studying Soft Tissue Sarcoma. Study availability and eligibility vary by location and protocol.

197 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Soft Tissue Sarcoma trial results

Completed

A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

NCT02451943

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Leiomyosarcoma, +10 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 114 locations
View Trial Details
Completed

Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma

NCT00742963

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Stanford University Stanford, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View Trial Details
Completed

Collecting and Storing Tissue From Young Patients With Cancer

NCT00898755

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Central Nervous System Neoplasm, +47 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Completed

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +55 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View all 16 locations
View Trial Details
Completed

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

NCT05697198

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +68 more
Locations
  • Clinical Site Fort Payne, Alabama, United States
  • Clinical Site Orange City, Florida, United States
  • Clinical Site Stuart, Florida, United States
  • Clinical Site Dublin, Georgia, United States
View Trial Details
Completed

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

NCT03220035

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +67 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 116 locations
View Trial Details

Related conditions